AI assistant
Sending…
TuHURA Biosciences, Inc./NV — Director's Dealing 2021
May 3, 2021
34026_dirs_2021-05-03_de67c9f5-f1d6-4988-8096-92b8e8af350b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Kintara Therapeutics, Inc. (KTRA)
CIK: 0001498382
Period of Report: 2021-04-29
Reporting Person: SEYMOUR TAMARA A (Director)
More from TuHURA Biosciences, Inc./NV
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 1
Director's Dealing
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17